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Summary Sentence
Transcriptome profiling of 57 endometrial receptivity genes specifies the menstrual cycle phase of
endometrial samples.
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Dear Editor,
Here we report the usability of a panel of transcriptomic markers to
determine the menstrual cycle phase of undated endometrial tissue
samples for gene expression studies. Endometrial tissue transcrip-
tomic studies are an important approach to find molecular charac-
teristics and biomarkers of endometriosis and other endometrium-
related diseases. However, endometrial gene expression is under
strict hormonal control and the menstrual cycle phase-specific sig-
nature has to be considered in molecular studies of reproductive age
women to avoid false-positive or -negative findings that may occur
if studied individuals are from different menstrual cycle phases. The
endometrial specimens’ collection is generally well tolerated by pa-
tients: however, unnecessary procedures can be avoided if archival
well-preserved RNA samples are available for research. Still, the use
of archival samples may be complicated if there is no accompanying
menstrual cycle information or only patients’ self-reportedmenstrual
cycle day is available, and no tissue has been left for histological
evaluation and classification of samples. Although the self-reported
menstrual cycle history has been extensively used in molecular stud-
ies, the length of the normal menstrual cycle varies between 24 and
35 days and thus self-reported menstrual history or calendar-based
counting methods are insufficient to accurately determine menstrual
cycle phase, or discriminate ovulatory cycles from anovulatory cy-
cles [1]. Ponnampalam et al. [2] utilized high-throughput microarray
technology and demonstrated that classification of the endometrial
samples according to the global transcriptional profile is concor-
dant with the histological evaluation. However, as global expression
profiling is rather costly, we aimed to use a new cost-effective Tar-
geted Allele Counting by sequencing (TAC-seq) methodology [3] to
explore the capability of a panel of 57 well-described endometrial re-
ceptivity genes [4] to determine the exact molecular menstrual cycle
phases of endometrial samples.
For that purpose, RNA was extracted from endometrial tissue
samples collected from 45 women with and 33 women without en-
dometriosis (suffering from pelvic pain or infertility) in menstrual
(M, cycle days 1–5, n = 4), proliferative (P, cycle days 6–14, n = 17),
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Figure 1. Multidimensional scaling plot of normalized RNA sequencing data of 57 endometrial receptivity genes in women with and without endometriosis.
(A) Clustering analysis of RNA sequencing data. (B) Clustering after applying support vector machine classifier to ES and MS phase samples. P—proliferative,
ES—early secretory, MS—mid-secretory, LS—late secretory, M—menstrual phase endometrial samples. Triangles represent women without endometriosis and
circles mark women with endometriosis.
early-secretory (ES, cycle days 15–18, n = 19), mid-secretory (MS,
cycle days 19–23, n = 19), and late-secretory (LS, cycle days 24–28,
n = 19) phases according to the self-reported menstrual cycle days
(Supplementary Table S1 and Supplementary Materials and Meth-
ods). The average age of women with and without endometriosis
was 31.0 ± 4.7 and 32.0 ± 5.1 years, respectively, and they had
not received any hormonal treatments for at least 3 months prior
to the laparoscopy in Tartu University Hospital (Tartu, Estonia).
The TAC-seq libraries were sequenced with NextSeq 500/550 v2.5
Kit (Illumina). Sequencing data analysis was performed as described
previously [3], and each sample was normalized using geometric
mean of gene expression levels of four housekeeper genes. The same
sequencing protocol was applied to 54 paired endometrial samples
from 27 healthy parous women, collected at the histologically and
biochemically [predicted from the luteinizing hormone (LH) peak
in urine] confirmed ES and MS cycle phases (described in [5]). The
resulting data were used to create a machine learning support vec-
tor machine (SVM) model for discrimination of ES and MS phase
samples.
Multidimensional scaling plot of normalized RNA sequencing
data showed that expression pattern of the 57 endometrial recep-
tivity genes divided the samples roughly into four distinct groups
(Figure 1A). Also, no clear segregation was seen between women
with and without endometriosis, which is concordant with a re-
cent study by Garcia-Velasco et al. [6]. All endometrial samples
from P phase clustered together and a subset of LS phase samples
(n = 8) formed a distinct cluster; however, several samples from LS
phase (n = 8) were more similar to MS samples and two LS sam-
ples grouped together with M phase samples. A similar phenomenon
was described by Ponnampalam et al. [2], who suggested that the
menstrual cycle is a continuum and the samples from the board-
ers of cycle phases may cluster to the adjacent phases. Interestingly,
one LS sample showed similar gene expression pattern to P samples.
We hypothesized that expression of the receptivity-related genes in
anovulatory cycles remains similar to P phase throughout the cycle.
Although the data about the endometrial receptivity-specific gene
expression signature in women with anovulatory menstrual cycles
is scarce, the level of glycodelin, which normally increases consider-
ably and stays elevated during the secretory phase, has been shown
to remain low throughout the anovulatory cycle [7]. The PAEP gene
encoding glycodelin was also among the 57 genes analyzed in the
current study and its low level in this LS sample was comparable to
P samples, supporting our assumption about anovulatory cycle.
Furthermore, ES and MS samples formed one diffuse cluster
(Figure 1A), indicating that self-reported menstrual cycle day does
not allow reliable distinction between samples from these adjacent
phases. Thereafter, the SVM model was successfully applied to seg-
regate the studied self-reported ES and MS samples (Figure 1B)
according to the receptivity gene expression pattern in endometrial
tissues from women in biochemically confirmed ES and MS phases.
After adjustment, 4 out of 19 ES phase samples were re-classified as
MS samples and 9MS samples were re-classified as ES, showing that
molecular profiling helped to assign the endometrial samples from
adjacent phases correctly even without precise chronological dating.
The most widely used method to assign the endometrial samples
collected at the second half of the cycle to ES or MS phase is deter-
mination of the LH peak from urine, which correlates significantly
better with the histological dating than the calculations based on
the onset of the next menstrual period [8]. However, as collection
of tissue samples for research is for ethical reasons usually com-
bined with clinical procedures that are scheduled long in advance,
it is difficult if not impossible to obtain specimens at the particu-
lar LH day. Furthermore, the value of histological dating has been
questioned as there are too many confounding factors influencing
the interpretation of the results [9]. Therefore, new molecular tools,
such as described in the current report, are useful to help specify
the precise menstrual cycle phase of not only archived endometrial
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phases in transcriptomic studies to facilitate the discovery of true
disease-related markers.
Supplementary data
Supplementary data are available at BIOLRE online.
Supplementary Table S1. General characteristics of the study
participants.
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